Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Ruth Ca?amar
Research Specialist, Principal
Cancer Center Division
Map Page
Research Area
clinical trial,
immunotherapy,
cancer,
oncology,
drug development,
combination therapy,
safety,
clinical trials,
monotherapy,
pharmacokinetics
Grants
(13)
A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XB002 As Single-Agent And Combination Therapy In Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
Active
·
2024
·
$0 / $1.6M
·
External
cancer,
pharmacokinetics,
drug therapy,
clinical trial,
tumor treatment
A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination with Other Anti-Cancer Therapies in Solid Tumors
Active
·
2024
·
$0 / $724K
·
External
cancer,
immunotherapy,
clinical trial,
monotherapy,
combination therapy
A Phase 1 Study With ABBV-CLS-484 Alone And In Combination In Subjects With Locally Advanced or Metastatic Tumors
Active
·
2024
·
$0 / $635K
·
External
oncology,
clinical trial,
cancer treatment,
drug development,
immunotherapy
A First-in-human, Multicenter, Open-label, Dose Escalation and Dose Expansion Phase 1 Study in Patients with Advanced Solid Tumors to Evaluate the Safety of Intravenously Administered ALG.APV-527
Active
·
2024
·
$0 / $348.6K
·
External
oncology,
clinical trials,
immunotherapy,
pharmacology,
drug safety
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects with Advanced Solid Tumors
Active
·
2023
·
$0 / $352.4K
·
External
cancer immunotherapy,
clinical trial,
tumor microenvironment,
intratumoral therapy,
solid tumors
Page 1 of 3
Previous page
Next page
Collaborations
(5)
Linda Garland
Mutual work: 5 Proposals﹒3 Grants
Collaboration Details
Gregory Woodhead
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Lizeth Evangelista
Mutual work: 13 Proposals﹒10 Grants
Collaboration Details
Shamar Young
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Alaina Krone
Mutual work: 1 Supervisor
Collaboration Details
4+ Collaborators
$0 / $5.9M Funding
10+ Grants
